IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
Clinical trial NCT06819293 · RECRUITING
Trial details
- NCT number
- NCT06819293
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2027-12-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.